Synopsys Is the Nasdaq 100’s Top Stock Today. The Target Says It’s Not Done
📈 Synopsys stock surged 8.8% to $474.28 after a strong Investor Day featuring major partnerships with OpenAI and Amazon.
💰 Fiscal Q3 revenue reached $2.48 billion, up 42.4% year over year, beating the $2.44 billion estimate.
🚀 Management raised full-year EPS guidance to $15.04–$15.10, driven by new AI revenue streams from agentic EDA tools.
🤝 The company targets $400 million in revenue synergies from its Ansys integration by fiscal year 2027.
💵 Synopsys trades at a forward P/E of 23x, significantly cheaper than rival Cadence's 32x multiple despite faster growth.
📉 Analyst consensus price target is $553.77 with no 'Sell' ratings among the 23 analysts covering the stock.
⚠️ Risks include export controls tied to China, total debt of approximately $10 billion, and Q4 restructuring charges.
- Synopsys reported fiscal Q3 revenue of $2.48B, a 42.4% year-over-year increase that significantly outpaced the $2.44B analyst estimate.
- Non-GAAP EPS of $3.91 exceeded expectations of $3.67, demonstrating strong profitability despite integration costs.
- Management raised full-year EPS guidance to a range of $15.04–$15.10, signaling confidence in future growth trajectories.
- Strategic partnerships with OpenAI and Amazon include multi-year IP agreements and custom silicon deals that anchor the bull case.
- The company is pioneering 'subscription plus consumption' pricing for agentic EDA tools, with 20 customers currently testing these new AI revenue streams.
- Synopsys trades at a forward P/E of 23x, offering a valuation discount to rival Cadence (CDNS) which trades at 32x despite slower growth.
- The company successfully paid off $3.45B of debt in Q1 and expects free cash flow of approximately $2.6B for the current year.
- The bull case depends on the successful execution of the Ansys integration, with $400M in synergies not expected until FY27.